Kilitch Drugs (India) fundamental analysis

KILITCH

340

15.05 (-4.24%)
Last updated on 28 Nov, 2025 | 15:29 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Kilitch Drugs (India) Fundamentals

P/E Ratio

21.74

P/B Ratio

2.26

Div. Yield

0

Sector P/E

37.14

Sector P/B

0.85

Sec. Div. Yield

0.56

  • Kilitch Drugs (India) Fundamentals is currently trading with a P/E Ratio of 21.74, compared to the sector average of 37.14. Its P/B Ratio stands at 2.26, while the sector’s is 0.85. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Kilitch Drugs (India) Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Poor

  • Management

    Average

  • On its scorecard, Kilitch Drugs (India) reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.